Sally J. Schwarz, a professor of radiology at Washington University School of Medicine in St. Louis, is the new president of the Society of Nuclear Medicine and Molecular Imaging. She is the first pharmacist and only the fourth woman out of 60 presidents to hold the title.
Among Schwarz’s goals as president is to work with the Food and Drug Administration to ensure that safe and effective pharmaceuticals are widely available. She also will focus on a program to cross-train nuclear pharmacists and radiochemists in aspects of each other’s fields so members of both groups can be qualified to approve the release of manufactured radiopharmaceuticals.
Schwarz’s work focuses on the regulatory issues involved in the use of radioactive compounds for diagnostic or therapeutic purposes. She is also co-director of the Mallinckrodt Institute of Radiology Cyclotron Facility, which produces PET drugs for diagnostic purposes.